| 12201686 |
Compositions including a therapeutic antibodies and/or a checkpoint inhibitor and an integrin activating compound |
Darren G. Woodside, Upendra K. Marathi |
2025-01-21 |
| 11312685 |
Targeting nanoparticles |
Darren G. Woodside, Robert V. Market, Ronald J. Biediger, Richard A. Dixon, James T. Willerson +2 more |
2022-04-26 |
| 11311619 |
Integrin activator vaccine compositions |
Darren G. Woodside, Upendra K. Marathi |
2022-04-26 |
| 10716849 |
Methods of administering novel integrin activator vaccine compositions |
Darren G. Woodside, Upendra K. Marathi |
2020-07-21 |
| 10709781 |
Integrin activator checkpoint inhibitor compositions |
Darren G. Woodside, Upendra K. Marathi |
2020-07-14 |
| 10709780 |
Integrin activator vaccine compositions |
Darren G. Woodside, Upendra K. Marathi |
2020-07-14 |
| 10342866 |
Compositions and methods for immunotherapies comprising small molecule integrin receptor-ligand agonist adjuvants |
Darren G. Woodside, Upendra K. Marathi |
2019-07-09 |
| 10287264 |
Agonists that enhance binding of integrin-expressing cells to integrin receptors |
Ronald J. Biediger, William C. Gundlach, IV, Robert V. Market, Michael M. Savage |
2019-05-14 |
| 9512109 |
Agonists that enhance binding of integrin-expressing cells to integrin receptors |
Ronald J. Biediger, William C. Gundlach, IV, Robert V. Market, Michael M. Savage |
2016-12-06 |
| 6713604 |
Process to inhibit binding of the integrin &agr;4&bgr;1 , to VCAM-1 fibronectin and cyclic peptides thereof |
Timothy Kogan, Kaijun Ren, Pamela J. Beck |
2004-03-30 |
| 6087330 |
Process to inhibit binding of the integrin .alpha..sub.4 .beta..sub.1 to VCAM-1 or fibronectin and cyclic peptides therefor |
Timothy Kogan, Kaijun Ren, Pamela J. Beck |
2000-07-11 |
| 5510332 |
Process to inhibit binding of the integrin .alpha..sub.4 62 .sub.1 to VCAM-1 or fibronectin and linear peptides therefor |
Timothy Kogan, Kaijun Ren, Pamela J. Beck |
1996-04-23 |